503A pharmacy

A 503A pharmacy is a traditional compounding pharmacy: a state-licensed pharmacy where a licensed pharmacist prepares a medication for an individual patient with a prescription. The name comes from section 503A of the Federal Food, Drug, and Cosmetic Act, which sets the conditions a compounder must meet to be exempt from certain federal drug requirements.

The practical consequences of that exemption are what patients should understand. FDA states that drugs compounded under 503A conditions are not subject to current good manufacturing practice requirements — the CGMP rules that govern how approved drugs are made and tested. Day-to-day oversight sits primarily with state boards of pharmacy, not FDA, though FDA does conduct surveillance and for-cause inspections of these pharmacies.

That does not make 503A pharmacies illegitimate. It makes them a different regulatory category than the one most people imagine when they picture a drug factory. A good 503A pharmacy runs sterility testing, potency assays and environmental monitoring because it chooses to, and because state rules and accreditation standards require it. A bad one may do far less, and the federal floor is lower than at a 503B outsourcing facility.

The common misunderstanding is that a 503A pharmacy can compound anything. It cannot. Federal law restricts what bulk substances may be used, prohibits copying commercially available approved drugs outside defined circumstances, and bars compounding of biologics entirely. FDA has warned distributors and telehealth companies over GLP-1 substances that fall outside those limits.

If a compounded prescription is on the table, ask which pharmacy fills it, whether it is 503A or 503B, whether it holds PCAB accreditation, and whether it will share a certificate of analysis for your lot. Our pharmacy lookup tool and state-by-state legality guide go further.